While both IFNα and IFNβ have anti-dengue activity in vitro, previous clinical studies had limited to the measurement of IFNα levels, and most had been performed in subjects with either DENV2 or DENV3 infections [10], [11], [21]. Here, IFNA1 is linked to infection.